Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study

医学 血液透析 危险系数 内科学 队列研究 前瞻性队列研究 队列 比例危险模型 累积发病率 置信区间 外科
作者
Shigeru Tanaka,Toshiharu Ninomiya,Masatomo Taniguchi,Kiichiro Fujisaki,Masanori Tokumoto,Hideki Hirakata,Hiroaki Ooboshi,Takanari Kitazono,Kazuhiko Tsuruya
出处
期刊:Nephrology Dialysis Transplantation [Oxford University Press]
卷期号:31 (7): 1152-1160 被引量:23
标识
DOI:10.1093/ndt/gfw205
摘要

Hemodialysis patients who receive vitamin D receptor activator (VDRA) reportedly have better survival after infection than those who do not. However, the optimal route of its administration for minimizing death from infection remains unclear. This prospective cohort study aimed to compare the effectiveness of oral versus intravenous VDRA regarding infection-related mortality in 3372 hemodialysis patients. Eligible subjects were divided into the following three groups by route of administration of VDRA: oral (n = 1868), intravenous (n = 492) and not administered (n = 1012). The effect of VDRA on infection-related mortality was examined using a Cox regression model with propensity score-based adjustments. During follow-up (median, 4.0 years), 118 study patients died of infection. There was a significantly lower incidence of death from infection in subjects who received intravenous VDRA than in those who did not receive VDRA; however, oral VDRA did not significantly reduce the risk of mortality from infection compared with those who did not receive VDRA [hazard ratio (HR) for intravenous VDRA, 0.16; 95% confidence interval (CI), 0.10–0.25, and HR for oral VDRA, 0.78; 95% CI, 0.60–1.01]. Direct comparison between the oral and intravenous VDRA groups showed that the intravenous group had significantly better survival than the oral group (HR, 0.39; 95% CI, 0.27–0.62). Treatment with intravenous VDRA more effectively reduces the incidence of mortality from infection than oral VDRA in hemodialysis patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源应助zgh采纳,获得10
1秒前
1秒前
宋宋发布了新的文献求助10
3秒前
学习通发布了新的文献求助10
6秒前
完美世界应助吴祥坤采纳,获得10
6秒前
ikun发布了新的文献求助10
6秒前
无花果应助冬至季采纳,获得10
7秒前
whale完成签到,获得积分10
8秒前
10秒前
kuyi完成签到 ,获得积分10
11秒前
11秒前
12秒前
一心向雨完成签到,获得积分10
13秒前
丘比特应助澜澜采纳,获得10
16秒前
16秒前
ljx发布了新的文献求助10
17秒前
负责的寒梅完成签到,获得积分10
19秒前
pluto应助天气好好采纳,获得10
20秒前
英姑应助明理采珊采纳,获得10
22秒前
忧伤的真菌完成签到,获得积分10
23秒前
量子星尘发布了新的文献求助10
25秒前
25秒前
25秒前
bkagyin应助魏少爷采纳,获得10
26秒前
无花果应助澡雪采纳,获得10
28秒前
29秒前
29秒前
31秒前
Hello应助Gtingting采纳,获得10
31秒前
深情安青应助宋宋采纳,获得10
31秒前
小药丸完成签到,获得积分10
31秒前
冬至季发布了新的文献求助10
31秒前
开花发布了新的文献求助10
32秒前
sciDoge发布了新的文献求助10
32秒前
33秒前
33秒前
风之子完成签到,获得积分10
34秒前
明理采珊发布了新的文献求助10
35秒前
丰富莹芝发布了新的文献求助10
35秒前
37秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975814
求助须知:如何正确求助?哪些是违规求助? 3520123
关于积分的说明 11201020
捐赠科研通 3256502
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877523
科研通“疑难数据库(出版商)”最低求助积分说明 806417